Meeting
2022 ASCO Genitourinary Cancers Symposium
Treatment outcomes of patients with metastatic prostate cancer and co-morbid diabetes mellitus.
Authors
Srinivas Govindan
Saint Louis University School of Medicine, Saint Louis, MO
Srinivas Govindan , Suhong Luo , Nina Cheranda , Forest Riekhof , Martin W. Schoen
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Therapeutics
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 113)
DOI
10.1200/JCO.2022.40.6_suppl.113
Abstract #
113
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Final study analysis of PRINT: Prostate cancer intensive, non–cross-reactive therapy for CRPC.
First Author: Bobby Chi-Hung Liaw
Poster
2023 ASCO Genitourinary Cancers Symposium
Survival outcomes in metastatic castration-resistant prostate cancer in the up-front treatment era.
First Author: Shunsuke Kamijo
Poster
2023 ASCO Genitourinary Cancers Symposium
Survival in Black and non-Black patients with metastatic prostate cancer.
First Author: Nina Cheranda
Poster
2022 ASCO Genitourinary Cancers Symposium
Survival of patients with metastatic prostate cancer and comorbid obesity.
First Author: Nina Cheranda